Belong Consultancy

Belong Consultancy has provided targeted executive search solutions from our London base. Our dedicated team excels in recruiting pivotal leadership roles across Banking & Financial Services and the Life Sciences sector throughout the United Kingdom, consistently identifying exceptional talent for complex remits.

Belong Consultancy is a boutique executive search firm, specialising in building senior and executive teams for the Financial Services and Life Sciences industries across the United Kingdom and United States.\n\nBelong was created to be different – a strategic partner for clients and a trusted advisor to candidates – offering an exclusive white-glove service like no other search firm.\n\nFINANCIAL SERVICES\n\nBelong was established in 2019 and has since built senior leadership teams for challenger banks, lenders, FinTech start-ups and scale-ups, and investment firms worldwide.\n\nWorking closely with Founders, CEOs and investors, Jessica and her team have established first-time leadership and C-Suites for high-growth Financial Services firms, as well as guiding scale-ups and established businesses through critical transformations.\n\nWe have a proven track record of delivering on C-Suite, VP, Head Of and Senior Manager positions across Finance, Technology, Operations, Risk, Compliance, Legal, Commercial and People functions, as well CEO and board appointments.\n\nLIFE SCIENCES\n\nHowever, in 2025, everything changed.\n\nJessica's mother was diagnosed with Stage 4 terminal cancer. Balancing oncology appointments, hospital visits and full-time caring alongside running Belong Consultancy inspired a new purpose: to do more good. \n\nBelong Consultancy evolved to serve not only Financial Services, but also Life Sciences – with a particular focus on Oncology and a mission to help cure cancer. \n\nWe work closely with Founders and investors to place Chief Medical Officers, Chief Scientific Officers, Chief Technical Officers, Chief Operating Officers – as well as the SVP, VP and Head Of roles supporting them – into biotechnology and pharmaceutical organisations at the forefront of cancer drug development.\n\n